{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:47:39Z","timestamp":1789789659463,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["Faculty funds"],"award-info":[{"award-number":["Faculty funds"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10549-025-07771-x","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T11:17:39Z","timestamp":1752146259000},"page":"225-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ"],"prefix":"10.1007","volume":"213","author":[{"given":"Lavinia P.","family":"Middleton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George H.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Whitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Mouabbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese B.","family":"Bevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"2","key":"7771_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1158\/1078-0432.CCR-18-1103","volume":"25","author":"JY Lee","year":"2019","unstructured":"Lee JY, Schizas M, Geyer FC et al (2019) Lobular Carcinomas In Situ display intralesion genetic heterogeneity and clonal evolution in the progression to invasive cobular carcinoma. Clin Cancer Res 25(2):674\u2013686. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1103","journal-title":"Clin Cancer Res"},{"issue":"1","key":"7771_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.path.2017.09.009","volume":"11","author":"HY Wen","year":"2018","unstructured":"Wen HY, Brogi E (2018) Lobular carcinoma in situ. Surg Pathol Clin 11(1):123\u2013145. https:\/\/doi.org\/10.1016\/j.path.2017.09.009","journal-title":"Surg Pathol Clin"},{"issue":"33","key":"7771_CR3","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","volume":"33","author":"TA King","year":"2015","unstructured":"King TA, Pilewskie M, Muhsen S et al (2015) Lobular Carcinoma in Situ: A 29-Year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol 33(33):3945\u20133952. https:\/\/doi.org\/10.1200\/JCO.2015.61.4743","journal-title":"J Clin Oncol"},{"issue":"24","key":"7771_CR4","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","volume":"23","author":"PJ Chuba","year":"2005","unstructured":"Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, Aref A (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23(24):5534\u20135541. https:\/\/doi.org\/10.1200\/JCO.2005.04.038","journal-title":"J Clin Oncol"},{"issue":"4","key":"7771_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3322\/canjclin.32.4.234","volume":"17","author":"FW Foote","year":"1941","unstructured":"Foote FW, Stewart FW (1941) Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 17(4):491-496.3. https:\/\/doi.org\/10.3322\/canjclin.32.4.234","journal-title":"Am J Pathol"},{"issue":"11","key":"7771_CR6","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1097\/PAS.0b013e31817dc3a6","volume":"32","author":"M Chivukula","year":"2008","unstructured":"Chivukula M, Haynik DM, Brufsky A, Carter G, Dabbs DJ (2008) Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol 32(11):1721\u20131726. https:\/\/doi.org\/10.1097\/PAS.0b013e31817dc3a6","journal-title":"Am J Surg Pathol"},{"key":"7771_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.breast.2017.12.011","volume":"38","author":"YA Masannat","year":"2018","unstructured":"Masannat YA, Husain E, Roylance R et al (2018) Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ. Breast 38:120\u2013124. https:\/\/doi.org\/10.1016\/j.breast.2017.12.011","journal-title":"Breast"},{"issue":"12","key":"7771_CR8","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.ejso.2019.07.011","volume":"45","author":"MP Foschini","year":"2019","unstructured":"Foschini MP, Miglio R, Fiore R et al (2019) Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: report of a large multi-institutional series and review of the literature. Eur J Surg Oncol 45(12):2279\u20132286. https:\/\/doi.org\/10.1016\/j.ejso.2019.07.011","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"7771_CR9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10549-024-07261-6","volume":"205","author":"HL Chung","year":"2024","unstructured":"Chung HL, Middleton LP, Sun J, Whitman GJ (2024) Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants. Breast Cancer Res Treat 205(3):545\u2013554. https:\/\/doi.org\/10.1007\/s10549-024-07261-6","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"7771_CR10","doi-asserted-by":"publisher","first-page":"e449","DOI":"10.1016\/j.clbc.2017.10.004","volume":"18","author":"T Guo","year":"2018","unstructured":"Guo T, Wang Y, Shapiro N, Fineberg S (2018) Pleomorphic lobular carcinoma in situ diagnosed by breast core biopsy: clinicopathologic ceatures and correlation with subsequent excision. Clin Breast Cancer 18(4):e449\u2013e454. https:\/\/doi.org\/10.1016\/j.clbc.2017.10.004","journal-title":"Clin Breast Cancer"},{"issue":"11","key":"7771_CR11","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1097\/01.pas.0000213290.58283.82","volume":"30","author":"O Fadare","year":"2006","unstructured":"Fadare O, Dadmanesh F, Alvarado-Cabrero I et al (2006) Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: a clinicopathologic study of 18 cases. Am J Surg Pathol 30(11):1445\u20131453. https:\/\/doi.org\/10.1097\/01.pas.0000213290.58283.82","journal-title":"Am J Surg Pathol"},{"key":"7771_CR12","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.humpath.2013.04.004","volume":"44","author":"SJ Shin","year":"2013","unstructured":"Shin SJ, Lal A, De Vries S et al (2013) Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. Hum Pathol 44:1998\u20132009","journal-title":"Hum Pathol"},{"key":"7771_CR13","unstructured":"NCCN Practice Guidelines in Oncology, Breast Cancer Screening and Diagnosis, p25 https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdf Version 2.2025. Accessed 13 Apr 2025"},{"key":"7771_CR14","unstructured":"WHO classification of tumours editorial board (2019) Breast tumors. Lobular Carcinoma (5th edn). Lyon (France): International agency for research on cancer, pp 71\u201375"},{"issue":"3","key":"7771_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/PAS.0000000000001191","volume":"43","author":"ER Shamir","year":"2019","unstructured":"Shamir ER, Chen YY, Chu T, Pekmezci M, Rabban JT, Krings G (2019) Pleomorphic and florid lobular carcinoma in situ variants of the breast: a clinicopathologicstudy of 85 cases with and without invasive carcinoma from a single academic center. Am J Surg Pathol 43(3):399\u2013408. https:\/\/doi.org\/10.1097\/PAS.0000000000001191","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"7771_CR16","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s41379-020-0459-6","volume":"33","author":"BT Harrison","year":"2020","unstructured":"Harrison BT, Nakhlis F, Dillon DA, Soong TR, Garcia EP, Schnitt SJ, King TA (2020) Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations. Mod Pathol 33(7):1287\u20131297. https:\/\/doi.org\/10.1038\/s41379-020-0459-6","journal-title":"Mod Pathol"},{"issue":"1","key":"7771_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.1806","volume":"207","author":"JS Reis-Filho","year":"2005","unstructured":"Reis-Filho JS, Simpson PT, Jones C et al (2005) Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol 207(1):1\u201313. https:\/\/doi.org\/10.1002\/path.1806","journal-title":"J Pathol"},{"issue":"4","key":"7771_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","volume":"200","author":"TW Yen","year":"2005","unstructured":"Yen TW, Hunt KK, Ross MI et al (2005) Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200(4):516\u2013526. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2004.11.012","journal-title":"J Am Coll Surg"},{"issue":"1","key":"7771_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1148\/radiol.11102368","volume":"260","author":"ME Brennan","year":"2011","unstructured":"Brennan ME, Turner RM, Ciatto S, Marinovich ML, French JR, Macaskill P, Houssami N (2011) Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 260(1):119\u2013128. https:\/\/doi.org\/10.1148\/radiol.11102368","journal-title":"Radiology"},{"issue":"12","key":"7771_CR20","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1245\/s10434-016-5449-z","volume":"23","author":"M Morrow","year":"2016","unstructured":"Morrow M, Van Zee KJ, Solin LJ et al (2016) Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology consensus guideline on margins for breast conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Ann Surg Oncol 23(12):3801\u20133810. https:\/\/doi.org\/10.1245\/s10434-016-5449-z","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"7771_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.5858\/2010-0204-OA.1","volume":"135","author":"E Downs-Kelly","year":"2011","unstructured":"Downs-Kelly E, Bell D, Perkins GH, Sneige N, Middleton LP (2011) Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ. Arch Pathol Lab Med 135(6):737\u2013743. https:\/\/doi.org\/10.5858\/2010-0204-OA.1","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"7771_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/1097-0142(197808)42:2<737::aid-cncr2820420247>3.0.co;2-t","volume":"42","author":"CD Haagensen","year":"1978","unstructured":"Haagensen CD, Lane N, Lattes R, Bodian C (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42(2):737\u2013769. https:\/\/doi.org\/10.1002\/1097-0142(197808)42:2%3c737::aid-cncr2820420247%3e3.0.co;2-t","journal-title":"Cancer"},{"issue":"1","key":"7771_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00132583-199605000-00009","volume":"1","author":"AR Frost","year":"1996","unstructured":"Frost AR, Tsangaris TN, Silverberg SG (1996) Pleomorphic lobular carcinoma in situ. Pathol Case Rev 1(1):27\u201331","journal-title":"Pathol Case Rev"},{"issue":"10","key":"7771_CR24","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1097\/01.MP.0000027624.08159.19","volume":"15","author":"N Sneige","year":"2002","unstructured":"Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP (2002) Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 15(10):1044\u20131050. https:\/\/doi.org\/10.1097\/01.MP.0000027624.08159.19","journal-title":"Mod Pathol"},{"key":"7771_CR25","doi-asserted-by":"publisher","unstructured":"Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 11;361(9352):125-9. https:\/\/doi.org\/10.1016\/S0140-6736(03)12230-1. Erratum in: Lancet. 2003 Jun 7;361(9373):1994. PMID: 12531579","DOI":"10.1016\/S0140-6736(03)12230-1"},{"issue":"3","key":"7771_CR26","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1245\/s10434-015-4922-4","volume":"23","author":"F Nakhlis","year":"2016","unstructured":"Nakhlis F, Gilmore L, Gelman R et al (2016) Incidence of adjacent synchronous invasive carcinoma and\/or ductal carcinoma In-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020). Ann Surg Oncol 23(3):722\u2013728. https:\/\/doi.org\/10.1245\/s10434-015-4922-4","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"7771_CR27","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1245\/s10434-017-5978-0","volume":"24","author":"JM Racz","year":"2017","unstructured":"Racz JM, Carter JM, Degnim AC (2017) Lobular neoplasia and atypical ductal hyperplasia on core biopsy: current surgical management recommendations. Ann Surg Oncol 24(10):2848\u20132854. https:\/\/doi.org\/10.1245\/s10434-017-5978-0","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"7771_CR28","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jacr.2020.07.036","volume":"17","author":"MN Shehata","year":"2020","unstructured":"Shehata MN, Rahbar H, Flanagan MR, Kilgore MR, Lee CI, Ryser MD, Lowry KP (2020) Risk for upgrade to malignancy after breast core needle biopsy diagnosis of lobular neoplasia:a systematic review and meta-analysis. J Am Coll Radiol 17(10):1207\u20131219. https:\/\/doi.org\/10.1016\/j.jacr.2020.07.036","journal-title":"J Am Coll Radiol"},{"key":"7771_CR29","unstructured":"American Society of Breast Surgeons Resource Guide: Surgical Management of Benign or High-Risk Lesions https:\/\/www.breastsurgeons.org\/docs\/statements\/asbrs-rg-high-risk-lesions.pdf. Accessed 18 Apr 2025"},{"key":"7771_CR30","unstructured":"Amin MB et al (eds) (2017) AJCC Cancer Staging Manual 8th edn. Breast. Springer Nature, Springer International AG Switzerland, pp 589\u2013628"},{"issue":"6","key":"7771_CR31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/0046-8177(92)90321-s","volume":"23","author":"V Eusebi","year":"1992","unstructured":"Eusebi V, Magalhaes F, Azzopardi JG (1992) Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Hum Pathol 23(6):655\u2013662. https:\/\/doi.org\/10.1016\/0046-8177(92)90321-s","journal-title":"Hum Pathol"},{"issue":"10","key":"7771_CR32","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/0046-8177(92)90035-2","volume":"23","author":"N Weidner","year":"1992","unstructured":"Weidner N, Semple JP (1992) Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol 23(10):1167\u20131171. https:\/\/doi.org\/10.1016\/0046-8177(92)90035-2","journal-title":"Hum Pathol"},{"issue":"12","key":"7771_CR33","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1097\/00000478-200012000-00009","volume":"24","author":"LP Middleton","year":"2000","unstructured":"Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ (2000) Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 24(12):1650\u20131656. https:\/\/doi.org\/10.1097\/00000478-200012000-00009","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"7771_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.clbc.2016.06.003","volume":"16","author":"B Susnik","year":"2016","unstructured":"Susnik B, Day D, Abeln E et al (2016) Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 Cases. Clin Breast Cancer 16(6):507\u2013513. https:\/\/doi.org\/10.1016\/j.clbc.2016.06.003","journal-title":"Clin Breast Cancer"},{"issue":"7","key":"7771_CR35","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/his.12353","volume":"64","author":"T Khoury","year":"2014","unstructured":"Khoury T, Karabakhtsian RG, Mattson D et al (2014) Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases. Histopathology 64(7):981\u2013993. https:\/\/doi.org\/10.1111\/his.12353","journal-title":"Histopathology"},{"issue":"13","key":"7771_CR36","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1245\/s10434-015-4552-x","volume":"22","author":"MR Flanagan","year":"2015","unstructured":"Flanagan MR, Rendi MH, Calhoun KE, Anderson BO, Javid SH (2015) Pleomorphic lobular carcinoma in situ: radiologic-pathologic features and clinical management. Ann Surg Oncol 22(13):4263\u20134269. https:\/\/doi.org\/10.1245\/s10434-015-4552-x","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7771_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10549-017-4334-1","volume":"165","author":"M De Brot","year":"2017","unstructured":"De Brot M, Koslow Mautner S, Muhsen S et al (2017) Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review. Breast Cancer Res Treat 165(2):411\u2013420. https:\/\/doi.org\/10.1007\/s10549-017-4334-1","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"7771_CR38","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1245\/s10434-018-6591-6","volume":"25","author":"AA Desai","year":"2018","unstructured":"Desai AA, Jimenez RE, Hoskin TL, Day CN, Boughey JC, Hieken TJ (2018) Treatment outcomes for pleomorphic lobular carcinoma in situ of the breast. Ann Surg Oncol 25(10):3064\u20133068. https:\/\/doi.org\/10.1245\/s10434-018-6591-6","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"7771_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/tbj.12843","volume":"24","author":"CE Fasola","year":"2018","unstructured":"Fasola CE, Chen JJ, Jensen KC, Allison KH, Horst KC (2018) Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast. Breast J 24(1):66\u201369. https:\/\/doi.org\/10.1111\/tbj.12843","journal-title":"Breast J"},{"issue":"2","key":"7771_CR40","doi-asserted-by":"publisher","first-page":"462","DOI":"10.2214\/AJR.17.19088","volume":"211","author":"JL Savage","year":"2018","unstructured":"Savage JL, Jeffries DO, Noroozian M, Sabel MS, Jorns JM, Helvie MA (2018) Pleomorphic lobular carcinoma in situ: imaging features, upgrade rate, and clinical outcomes. AJR Am J Roentgenol 211(2):462\u2013467. https:\/\/doi.org\/10.2214\/AJR.17.19088","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"7771_CR41","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41379-021-00796-9","volume":"34","author":"MG Kuba","year":"2021","unstructured":"Kuba MG, Murray MP, Coffey K, Calle C, Morrow M, Brogi E (2021) Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision. Mod Pathol 34(8):1495\u20131506. https:\/\/doi.org\/10.1038\/s41379-021-00796-9","journal-title":"Mod Pathol"},{"issue":"4","key":"7771_CR42","doi-asserted-by":"publisher","first-page":"100462","DOI":"10.1016\/j.modpat.2024.100462","volume":"37","author":"L Harinath","year":"2024","unstructured":"Harinath L, Villatoro TM, Clark BZ et al (2024) Upgrade rates of variant lobular carcinoma in situ compared to classic lobular carcinoma in situ diagnosed in core needle biopsies: a 10-year single institution retrospective study. Mod Pathol 37(4):100462. https:\/\/doi.org\/10.1016\/j.modpat.2024.100462","journal-title":"Mod Pathol"},{"key":"7771_CR43","doi-asserted-by":"publisher","first-page":"3580992","DOI":"10.1155\/tbj\/3580992","volume":"2025","author":"A Desai","year":"2025","unstructured":"Desai A, Kesmodel SB, Susnik B, Goel N, Feliciano Y, Gomez-Fernandez C, Tjendra Y (2025) Florid lobular carcinoma in situ: imaging characteristics and pathologic upgrade rates on surgical excision. Breast J 2025:3580992. https:\/\/doi.org\/10.1155\/tbj\/3580992","journal-title":"Breast J"},{"issue":"8","key":"7771_CR44","doi-asserted-by":"publisher","first-page":"110021","DOI":"10.1016\/j.ejso.2025.110021","volume":"51","author":"M Ferrucci","year":"2025","unstructured":"Ferrucci M, Passeri D, Milardi F, Marchet A, Del Bianco P, Cappellesso R, Tos APD (2025) Clinical management and oncologic outcomes of pure pleomorphic and florid lobular carcinoma in situ of the breast: results from a large single institution experience. Eur J Surg Oncol 51(8):110021. https:\/\/doi.org\/10.1016\/j.ejso.2025.110021","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"7771_CR45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/cncr.11883","volume":"100","author":"ER Fisher","year":"2004","unstructured":"Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N (2004) Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer 100(2):238\u2013244. https:\/\/doi.org\/10.1002\/cncr.11883","journal-title":"Cancer"},{"issue":"4","key":"7771_CR46","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1245\/s10434-024-16686-8","volume":"32","author":"CJC Meurs","year":"2025","unstructured":"Meurs CJC, Kerkhoven C, Siesling S, Menke-Pluijmers MBE, Westenend PJ (2025) Surgery for classic, pleomorphic and non-classic lobular carcinoma in situ: surgery rate, risk of upstaging and short-term follow-up. Ann Surg Oncol 32(4):2545\u20132553. https:\/\/doi.org\/10.1245\/s10434-024-16686-8","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"7771_CR47","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/his.15390","volume":"86","author":"A Katayama","year":"2025","unstructured":"Katayama A, Makhlouf S, Toss MS, Oyama T, Rakha EA (2025) Nuclear morphological characterisation of lobular carcinoma variants: a morphometric study. Histopathology 86(5):813\u2013823. https:\/\/doi.org\/10.1111\/his.15390","journal-title":"Histopathology"},{"issue":"3","key":"7771_CR48","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-012-2318-8","volume":"136","author":"SB Coopey","year":"2012","unstructured":"Coopey SB, Mazzola E, Buckley JM et al (2012) The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat 136(3):627\u2013633. https:\/\/doi.org\/10.1007\/s10549-012-2318-8","journal-title":"Breast Cancer Res Treat"},{"key":"7771_CR49","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","volume":"16","author":"B Fisher","year":"1998","unstructured":"Fisher B, Dignam J, Wolmark N et al (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441\u2013452","journal-title":"J Clin Oncol"},{"issue":"32","key":"7771_CR50","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","volume":"31","author":"M Donker","year":"2013","unstructured":"Donker M, Liti\u00e8re S, Werutsky G, Julien JP, Fentiman IS, Agresti R, Rouanet P, de Lara CT, Bartelink H, Duez N, Rutgers EJ, Bijker N (2013) Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 31(32):4054\u20134059. https:\/\/doi.org\/10.1200\/JCO.2013.49.5077","journal-title":"J Clin Oncol"},{"key":"7771_CR51","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","volume":"32","author":"F W\u00e4rnberg","year":"2014","unstructured":"W\u00e4rnberg F, Garmo H, Emdin S et al (2014) Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS trial. J Clin Oncol 32:3613","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07771-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07771-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07771-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:26:55Z","timestamp":1757219215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07771-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["7771"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07771-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GW Disclosures. Editor- Up to Date. Consultant- Siemens. Vice President, Society of Breast Imaging. GW has received an honorarium from the Society of Breast Imaging for a Webinar. The authors have no relevant financial or non-financial interests to disclose","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of University of Texas MD Anderson Cancer Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived by the IRB as there is minimal risk to the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}